EMEA-001366-PIP01-12-M02
Key facts
| Invented name |
Sialanar
|
| Active substance |
glycopyrronium bromide
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0240/2014
|
| PIP number |
EMEA-001366-PIP01-12-M02
|
| Pharmaceutical form(s) |
Oral liquid
|
| Condition(s) / indication(s) |
Treatment of sialorrhoea
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Proveca Limited
E-mail: simon@proveca.co.uk |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-001366-PIP01-12-M02
|
| Compliance opinion date |
14/11/2014
|
| Compliance outcome |
positive
|